Klaus Budde

Title: Klaus Budde: Innovator in Controlled-Release Dosage Forms

Introduction

Klaus Budde is a notable inventor based in Burgwedel, Germany. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of controlled-release dosage forms. His innovative approach has led to advancements that enhance the efficacy and reliability of therapeutic medications.

Latest Patents

Klaus Budde holds a patent for a process titled "Process for the preparation of shaped, compressed controlled-release unit-dosage forms." This invention focuses on creating unit-dosage forms from therapeutic active substances that exhibit a self-retarding release mechanism. The process ensures that the release of the active substance is uniform, reproducibly identical, and largely linear. By processing the active substance with an additive charge, Budde's method allows for the production of preliminary compressed objects that achieve rapid release, followed by compression with a release-retarding agent to obtain the final dosage forms.

Career Highlights

Klaus Budde is associated with Boehringer Mannheim GmbH, where he has applied his expertise in pharmaceutical development. His work has been instrumental in advancing the technology behind controlled-release medications, which are crucial for improving patient outcomes. With a focus on innovation, Budde continues to contribute to the field through his research and development efforts.

Collaborations

Klaus Budde has collaborated with notable colleagues, including Alexander Wirl and Fritz Demmer. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the quality of their work in pharmaceutical innovations.

Conclusion

Klaus Budde's contributions to the field of controlled-release dosage forms exemplify the impact of innovative thinking in pharmaceuticals. His patent and ongoing work at Boehringer Mannheim GmbH highlight the importance of advancements in medication delivery systems. Through his efforts, Budde continues to shape the future of therapeutic treatments.